arrow
J

Javier Díez-Domingo

Fisabio
H指数:46
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study (vol 13, pg 1835, 2024)

四价脑膜炎球菌结合疫苗与Nimenrix在健康青少年中的免疫原性和安全性比较:一项随机IIIb期多中心研究(卷13,页1835,2024)

2025-04-240
OA
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis

影响欧洲老年人呼吸道合胞病毒疫苗接种成本效益的关键驱动因素:一项多国分析

2025-03-240
OA
Feasibility of a hybrid clinical trial for respiratory virus detection in toddlers during the influenza season (vol 21, 273, 2021)
2024-07-190
OAAI
Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study

流行病学和临床洞察肠病毒D68热潮在欧洲2021-2022和新的B3-Derived谱系的出现,ENPEN多中心研究

2024-03-288
OAAI
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024
2024-02-0847
OAAI
Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN)

流感相关住院严重程度的预测因素: 来自全球流感医院监测网络 (GIHSN) 的结果

2023-08-016
OA
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

ChAd155载体呼吸道合胞病毒疫苗在6-7个月婴儿中的安全性和免疫原性: 1/2期随机试验

2023-07-214
OAAI